Close Menu

NEW YORK (GenomeWeb) – Biocept filed an update with the US Securities and Exchange Commission today amending the preliminary prospectus it released in November for an offering of more than $9 million of its common stock with attached warrants to purchase additional shares.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.